摘要
目的探讨纳洛酮治疗小儿重症肺炎的临床疗效。方法对96例重症肺炎患儿随机分为治疗组和对照组,所有患儿根据病情给予对症治疗,治疗组在对照组的基础上加用纳洛酮静脉滴注,7 d为1个疗程,观察并比较两组症状和体征消失时间及临床疗效。结果治疗组心力衰竭症状及体征消失时间较对照组快;治疗组总有效率为95.8%,对照组为70.8%,两组疗效比较差异有统计学意义(P<0.01)。结论纳洛酮治疗小儿重症肺炎疗效显著,值得临床推广。
Objective To explore the clinical efficacy of severe children pneumonia treated by Naloxone.Methods 96 children with severe pneumonia were randomly divided into treatment group and control group,all children were given symptomatic treatment according to patient′s condition,the treatment group was added Naloxone intravenous drip based on control group,7 d as a treatment course,the extinction time of symptoms and physical signs and the clinical efficacy were observed.Results The extinction time of cardiac failure of treatment group was shorter than control group,the total efficacy rate of treatment group was 95.8%,and the control group was 70.8%,the clinical efficacy of two groups showed significant difference（P0.01）.Conclusion Naloxone is an effective treatment for severe children pneumonia,worthy of clinical promotion.
出处
《医学综述》
2012年第8期1268-1269,共2页
Medical Recapitulate
关键词
小儿重症肺炎
纳洛酮
治疗
Severe children pneumonia
Naloxone
Treatment
